Published Date: 08 Mar 2023
The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).
Read Full NewsResearchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.
A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.
1.
Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans
2.
Medicaid expansion tied to smaller declines in early-stage cancer detection
3.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
4.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
5.
The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.
1.
The benefits of using magnesium sulfate during pregnancy
2.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
3.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
4.
The Power of White Blood Cells: How They Help Keep Us Healthy
5.
Modern Strategies in Hematology for Specialists
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
4.
Thromboprophylaxis In Medical Settings
5.
Navigating the Complexities of Ph Negative ALL - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation